Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nonalcoholic Fatty Liver Disease, the Gut Microbiome, and Diet
Zeinab Mokhtari, Deanna L. Gibson, Azita Hekmatdoost
Advances in Nutrition (2017) Vol. 8, Iss. 2, pp. 240-252
Open Access | Times Cited: 148

Showing 1-25 of 148 citing articles:

Butyrate: A Double-Edged Sword for Health?
Hu Liu, Ji Wang, Ting He, et al.
Advances in Nutrition (2018) Vol. 9, Iss. 1, pp. 21-29
Open Access | Times Cited: 841
Intestinal Microbiome Shifts, Dysbiosis, Inflammation, and Non-alcoholic Fatty Liver Disease
Emma Saltzman, Talia Palacios, Michael Thomsen, et al.
Frontiers in Microbiology (2018) Vol. 9
Open Access | Times Cited: 168
Role of Microbiota-Gut-Brain Axis in Regulating Dopaminergic Signaling
Sevag Hamamah, Armin Aghazarian, Anthony Nazaryan, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 436-436
Open Access | Times Cited: 157
New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress
Domenico Ferro, Francesco Baratta, Daniele Pastori, et al.
Nutrients (2020) Vol. 12, Iss. 9, pp. 2762-2762
Open Access | Times Cited: 142
Nutritional composition and bioactive potential of watermelon seeds: a pathway to sustainable food and health innovation
Jasia Nissar, Urba Shafiq Sidiqi, Aamir Hussain Dar, et al.
Sustainable Food Technology (2025)
Open Access | Times Cited: 3
Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis
Brett R. Loman, Diego Hernández‐Saavedra, Ruopeng An, et al.
Nutrition Reviews (2018) Vol. 76, Iss. 11, pp. 822-839
Open Access | Times Cited: 130
Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial
Saeede Saadati, Amir Sadeghi, Asieh Mansour, et al.
BMC Gastroenterology (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 127
Histological improvement of non-alcoholic steatohepatitis with a prebiotic: a pilot clinical trial
Marc R. Bomhof, Jill A. Parnell, Hena R. Ramay, et al.
European Journal of Nutrition (2018) Vol. 58, Iss. 4, pp. 1735-1745
Closed Access | Times Cited: 121
Obese Adolescents With PCOS Have Altered Biodiversity and Relative Abundance in Gastrointestinal Microbiota
Beza Jobira, Daniel N. Frank, Laura Pyle, et al.
The Journal of Clinical Endocrinology & Metabolism (2020) Vol. 105, Iss. 6, pp. e2134-e2144
Open Access | Times Cited: 119
Contribution of the gut microbiota to the regulation of host metabolism and energy balance: a focus on the gut–liver axis
Nathalie M. Delzenne, Christelle Knudsen, Martín Beaumont, et al.
Proceedings of The Nutrition Society (2019) Vol. 78, Iss. 3, pp. 319-328
Open Access | Times Cited: 116
Bisphenol A exposure induces gut microbiota dysbiosis and consequent activation of gut-liver axis leading to hepatic steatosis in CD-1 mice
Dan Feng, Hongmin Zhang, Xin Jiang, et al.
Environmental Pollution (2020) Vol. 265, pp. 114880-114880
Closed Access | Times Cited: 114
Interactions between gut microbiota and non-alcoholic liver disease: The role of microbiota-derived metabolites
Yufang Ding, Karin Yanagi, Clint Cheng, et al.
Pharmacological Research (2019) Vol. 141, pp. 521-529
Open Access | Times Cited: 100
Correlation of gut Firmicutes/Bacteroidetes ratio with fibrosis and steatosis stratified by body mass index in patients with non-alcoholic fatty liver disease
Chyntia Olivia Maurine Jasirwan, Akhmadu Muradi, Irsan Hasan, et al.
Bioscience of Microbiota Food and Health (2020) Vol. 40, Iss. 1, pp. 50-58
Open Access | Times Cited: 91
Mediterranean Diet and Multi-Ingredient-Based Interventions for the Management of Non-Alcoholic Fatty Liver Disease
Manuel Suárez, Noemí Boqué, Josep M Del Bas-Prior, et al.
Nutrients (2017) Vol. 9, Iss. 10, pp. 1052-1052
Open Access | Times Cited: 90
Understanding the Effects of Gut Microbiota Dysbiosis on Nonalcoholic Fatty Liver Disease and the Possible Probiotics Role: Recent Updates
Ashiq Khan, Zitong Ding, Muhammad Ishaq, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 3, pp. 818-833
Open Access | Times Cited: 85
Mitochondrial dysfunction in nonalcoholic fatty liver disease and alcohol related liver disease
Pankaj Prasun, Ilona Ginevic, Kimihiko Oishi
Translational Gastroenterology and Hepatology (2020) Vol. 6, pp. 4-4
Open Access | Times Cited: 77
Epigallocatechin gallate but not catechin prevents nonalcoholic steatohepatitis in mice similar to green tea extract while differentially affecting the gut microbiota
Priyankar Dey, Bryan D. Olmstead, Geoffrey Y. Sasaki, et al.
The Journal of Nutritional Biochemistry (2020) Vol. 84, pp. 108455-108455
Open Access | Times Cited: 72
Role of Ferroptosis in Non-Alcoholic Fatty Liver Disease and Its Implications for Therapeutic Strategies
Han Zhang, Enxiang Zhang, Hongbo Hu
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1660-1660
Open Access | Times Cited: 63
A randomised placebo controlled trial of VSL#3® probiotic on biomarkers of cardiovascular risk and liver injury in non-alcoholic fatty liver disease
Pui Lin Chong, David W Laight, Richard Aspinall, et al.
BMC Gastroenterology (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 56
Lentinan Supplementation Protects the Gut–Liver Axis and Prevents Steatohepatitis: The Role of Gut Microbiota Involved
Xiaoying Yang, Mingxuan Zheng, Menglu Zhou, et al.
Frontiers in Nutrition (2022) Vol. 8
Open Access | Times Cited: 50
Beneficial effects of butyrate on brain functions: A view of epigenetic
Gabriela de Cássia Ávila Alpino, Gabriela Amorim Pereira Sol, Mariana de Moura e Dias, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 64, Iss. 12, pp. 3961-3970
Closed Access | Times Cited: 38
Gut microbiota: A magical multifunctional target regulated by medicine food homology species
Wei‐Fang Zuo, Qiwen Pang, Lai-Ping Yao, et al.
Journal of Advanced Research (2023) Vol. 52, pp. 151-170
Open Access | Times Cited: 28
Potential therapeutic implications of histidine catabolism by the gut microbiota in NAFLD patients with morbid obesity
Sergio Quesada‐Vázquez, Anna Castells‐Nobau, Jèssica Latorre, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 12, pp. 101341-101341
Open Access | Times Cited: 24
Effects of gut microbial therapy on lipid profile in individuals with non-alcoholic fatty liver disease: an umbrella meta-analysis study
Amirhossein Naghipour, Ehsan Amini‐Salehi, Mahdi Orang Gorabzarmakhi, et al.
Systematic Reviews (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 23
Smilax China L. polysaccharide prevents HFD induced-NAFLD by regulating hepatic fat metabolism and gut microbiota
Wenkai Zhang, Longhui Yu, Qinru Yang, et al.
Phytomedicine (2024) Vol. 127, pp. 155478-155478
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top